• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    TruBridge Announces Third Quarter 2024 Results

    11/7/24 5:00:00 PM ET
    $TBRG
    EDP Services
    Technology
    Get the next $TBRG alert in real time by email

    TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the third quarter and nine months ended September 30, 2024.

    Third Quarter 2024 Highlights*

    All comparisons are to the quarter ended September 30, 2023, unless otherwise noted

    • Total bookings of $21.0 million compared to $15.0 million
    • Total revenue of $83.8 million compared to $82.7 million
    • Financial Health revenue of $54.3 million compared to $46.6 million
      • Financial Health revenue represented 64.7% of TruBridge's total revenue
    • GAAP (loss) earnings per diluted share of $(0.66) compared to $(0.24)
    • Non-GAAP (loss) earnings per diluted share of $(0.21) compared to $0.45
    • GAAP net loss of $(9.8) million and non-GAAP net loss of $(3.0) million
    • Adjusted EBITDA of $13.8 million compared to $9.7 million

    *As of the third quarter of 2024, TruBridge is now reporting two segments in its financial statements representing the two business units. Financial Health represents the previous Revenue Cycle Management (RCM) segment, and Patient Care represents the previously reported Electronic Health Record (EHR) segment, including the patient engagement business.

    Commenting on the results, Chris Fowler, chief executive officer of TruBridge, Inc., stated, "We are pleased with the strong results our team delivered this quarter. Our Financial Health business is showing solid growth and adjusted EBITDA margin is expanding as anticipated. On a recent trip to India, I was able to witness firsthand the impressive work our team is doing to successfully execute the Viewgol integration. I am happy to report that everything is moving along smoothly, and we remain focused on optimizing operations and realizing margin improvements over time.

    "Our recently launched analytics offering is starting to resonate with our initial customers, and we believe that, over time, it has the potential to become a contributor to our growth strategy. We have delivered consistent results so far in 2024, made steady progress on our ongoing initiatives and generated bookings and a pipeline that give us confidence in our outlook as we move into 2025," concluded Fowler.

    Executive Leadership Changes

    TruBridge also announced today the elevation of the Company's business unit general managers to report directly to the Company's Chief Executive Officer, reflecting the expanded scope and evolution of these roles. In conjunction with this move, David Dye will be retiring from his role as Chief Operating Officer, effective December 31, 2024, at which time the Company will eliminate that position. He will serve the remainder of his board term through completion in 2026. Dye has been with the Company since 1990, having held many roles in addition to his current position, including Chairman, Chief Growth Officer, President and Chief Executive Officer, and Chief Financial Officer.

    Glenn Tobin, chairman of the Company's Board of Directors, added, "On behalf of our Board of Directors and the entire TruBridge organization, I want to express my appreciation for David and his decades of contribution. David's leadership and numerous accomplishments have been integral to TruBridge's success, and his positive impact has been felt by many employees over the years."

    Financial Guidance

    For the fourth quarter of 2024, TruBridge expects to generate:

    • Total revenue between $83.5 million and $85.5 million
    • Adjusted EBITDA between $13.5 million and $14.5 million

    For the full year 2024, TruBridge expects to generate:

    • Total revenue of $335 million and $337 million; narrowed from $330 million and $340 million
    • Adjusted EBITDA of $49 million and $50 million; narrowed from $45 million and $50 million

    Conference Call

    TruBridge will hold a conference call and live webcast to discuss third quarter 2024 results on Friday, November 8, 2024, at 8:00 a.m. Central time/9:00 a.m. Eastern time. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company's investor relations website, investors.trubridge.com.

    About TruBridge

    We are a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative data-driven solutions that create real value by supporting both the financial and clinical side of healthcare delivery. Our industry leading HFMA Peer Reviewed® suite of revenue cycle management (RCM) offerings combine unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings. We support efficient patient care with electronic health record (EHR) product offerings that successfully integrate data between care settings. Above all, we believe in the power of community and encourage collaboration, connection, and empowerment with our customers. We clear the way for care. For more information, please visit www.trubridge.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as "expects," "anticipates," "estimates," "believes," "predicts," "intends," "plans," "potential," "may," "continue," "should," "will" and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company's future financial and operational results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; pandemics and other public health crises and related economic disruptions; transition to a subscription-based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified client service and support personnel; disruption from periodic restructuring of our sales force; potential delay in the development of markets for our RCM service offering; potential inability to properly manage growth in new markets we may enter; potential disruption of our business due to our ongoing implementation of a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our international business activities; potential litigation against us; our reliance on an international workforce which exposes us to various business disruptions; our utilization of artificial intelligence, which could expose us to liability or adversely affect our business if we cannot compete effectively with others using artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to function properly resulting in claims for medical and other losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions, including bank failures or changes in related regulation; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.

    TruBridge, Inc.
    Condensed Consolidated Statements of Income
    (In '000s, except per share data)
    (Unaudited)
     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    2024

     

    2023

     

    2024

     

    2023

    Revenues
    Financial Health

    $

    54,271

     

    $

    46,582

     

    $

    161,417

     

    $

    142,973

     

    Patient Care

     

    29,559

     

     

    36,130

     

     

    90,389

     

     

    110,594

     

    Total revenues

     

    83,830

     

     

    82,712

     

     

    251,806

     

     

    253,567

     

     
    Expenses
    Costs of revenue (exclusive of amortization and depreciation)
    Financial Health

     

    29,185

     

     

    27,159

     

     

    89,051

     

     

    81,461

     

    Patient Care

     

    13,184

     

     

    16,704

     

     

    38,421

     

     

    50,712

     

    Total costs of revenue (exclusive of amortization and depreciation)

     

    42,369

     

     

    43,863

     

     

    127,472

     

     

    132,173

     

    Product development

     

    7,735

     

     

    9,778

     

     

    26,629

     

     

    26,899

     

    Sales and marketing

     

    5,944

     

     

    6,818

     

     

    20,351

     

     

    21,906

     

    General and administrative

     

    19,376

     

     

    20,961

     

     

    57,651

     

     

    54,471

     

    Amortization

     

    6,183

     

     

    6,208

     

     

    21,158

     

     

    17,549

     

    Depreciation

     

    279

     

     

    297

     

     

    1,079

     

     

    1,392

     

    Total expenses

     

    81,886

     

     

    87,925

     

     

    254,340

     

     

    254,390

     

     
    Operating income (loss)

     

    1,944

     

     

    (5,213

    )

     

    (2,534

    )

     

    (823

    )

     
    Other income (expense):
    Other income (expense)

     

    (376

    )

     

    224

     

     

    1,139

     

     

    569

     

    Interest expense

     

    (4,033

    )

     

    (3,071

    )

     

    (12,348

    )

     

    (8,405

    )

    Total other expense

     

    (4,409

    )

     

    (2,847

    )

     

    (11,209

    )

     

    (7,836

    )

     
    Loss before taxes

     

    (2,465

    )

     

    (8,060

    )

     

    (13,743

    )

     

    (8,659

    )

     
    Income tax expense (benefit)

     

    7,344

     

     

    (4,498

    )

     

    3,631

     

     

    (5,344

    )

     
    Net loss

    $

    (9,809

    )

    $

    (3,562

    )

    $

    (17,374

    )

    $

    (3,315

    )

     
    Net loss per common share—basic

    $

    (0.66

    )

    $

    (0.24

    )

    $

    (1.17

    )

    $

    (0.23

    )

    Net loss per common share—diluted

    $

    (0.66

    )

    $

    (0.24

    )

    $

    (1.17

    )

    $

    (0.23

    )

     
    Weighted average shares outstanding used in per common share computations:
    Basic

     

    14,323

     

     

    14,205

     

     

    14,290

     

     

    14,181

     

    Diluted

     

    14,323

     

     

    14,205

     

     

    14,290

     

     

    14,181

     

    TruBridge, Inc.
    Condensed Consolidated Balance Sheets
    (In '000s, except per share data)
     
    September 30,

    2024

    (Unaudited)
    Dec. 31, 2023
    Assets
    Current assets
    Cash and cash equivalents

    $

    8,586

     

    $

    3,848

     

    Accounts receivable, net of allowance for expected credit losses of $3,896 and $3,631, respectively

     

    56,680

     

     

    59,723

     

    Financing receivables, current portion (net of allowance for expected credit losses of $405 and $319, respectively)

     

    5,133

     

     

    3,997

     

    Inventories

     

    924

     

     

    475

     

    Prepaid income taxes

     

    1,972

     

     

    1,628

     

    Prepaid expenses and other

     

    15,853

     

     

    15,807

     

    Assets of held for sale

     

    2,473

     

     

    25,977

     

    Total current assets

     

    91,621

     

     

    111,455

     

     
    Property & equipment, net

     

    5,049

     

     

    8,974

     

    Software development costs, net

     

    41,026

     

     

    39,139

     

    Operating lease assets

     

    3,451

     

     

    5,192

     

    Financing receivables, net of current portion (net of allowance for expected credit losses of $18 and $97, respectively)

     

    231

     

     

    1,226

     

    Other assets, net of current portion

     

    7,749

     

     

    7,314

     

    Intangible assets, net

     

    79,833

     

     

    89,213

     

    Goodwill

     

    172,573

     

     

    171,909

     

    Total assets

    $

    401,533

     

    $

    434,422

     

     
    Liabilities & Stockholders' Equity
    Current liabilities
    Accounts payable

    $

    14,028

     

    $

    10,133

     

    Current portion of long-term debt

     

    2,926

     

     

    3,141

     

    Deferred revenue

     

    10,235

     

     

    8,677

     

    Accrued vacation

     

    5,392

     

     

    5,410

     

    Other accrued liabilities

     

    18,421

     

     

    19,892

     

    Liabilities of held for sale

     

    -

     

     

    977

     

    Total current liabilities

     

    51,002

     

     

    48,230

     

     
    Long-term debt, net of current portion

     

    173,343

     

     

    195,270

     

    Operating lease liabilities, net of current portion

     

    2,520

     

     

    3,074

     

    Deferred tax liabilities

     

    2,021

     

     

    1,230

     

    Total liabilities

     

    228,886

     

     

    247,804

     

     
    Stockholders' Equity
    Common stock, $0.001 par value; 30,000 shares authorized; 15,546 and 15,121 shares issued, respectively

     

    15

     

     

    15

     

    Additional paid-in capital

     

    199,244

     

     

    195,546

     

    Accumulated other comprehensive gain

     

    107

     

     

    -

     

    Accumulated (deficit) earnings

     

    (9,242

    )

     

    8,132

     

    Treasury stock, 619 and 572 shares, respectively

     

    (17,477

    )

     

    (17,075

    )

    Total stockholders' equity

     

    172,647

     

     

    186,618

     

     
    Total liabilities and stockholders' equity

    $

    401,533

     

    $

    434,422

     

    TruBridge, Inc.
    Condensed Consolidated Statements of Cash Flows
    (In '000s)
    (Unaudited)
     

    Nine Months Ended September 30,

    2024

    2023

    Operating activities:
    Net loss

    $

    (17,374

    )

    $

    (3,315

    )

    Adjustments to net loss:
    Provision for credit losses

     

    1,046

     

     

    810

     

    Deferred taxes

     

    915

     

     

    (8,171

    )

    Stock-based compensation

     

    3,698

     

     

    2,162

     

    Depreciation

     

    1,079

     

     

    1,392

     

    Gain on sale of business

     

    (1,221

    )

     

    -

     

    Amortization of acquisition-related intangibles

     

    9,379

     

     

    12,043

     

    Amortization of software development costs

     

    11,779

     

     

    5,506

     

    Amortization of deferred finance costs

     

    320

     

     

    269

     

    Change in fair value of contingent consideration

     

    (1,044

    )

     

    -

     

    Non-cash operating lease costs

     

    1,879

     

     

    1,478

     

    Loss on disposal of property and equipment

     

    1,648

     

     

    117

     

    Changes in operating assets and liabilities:
    Accounts receivable

     

    2,946

     

     

    (8,632

    )

    Financing receivables

     

    (129

    )

     

    2,029

     

    Inventories

     

    (449

    )

     

    (157

    )

    Prepaid expenses and other

     

    3,228

     

     

    (1,972

    )

    Accounts payable

     

    3,925

     

     

    6,333

     

    Deferred revenue

     

    2,162

     

     

    (2,784

    )

    Operating lease liabilities

     

    (1,415

    )

     

    (1,462

    )

    Other liabilities

     

    (189

    )

     

    6,656

     

    Prepaid income taxes

     

    (344

    )

     

    1,017

     

    Net cash provided by operating activities

     

    21,839

     

     

    13,319

     

     
    Investing activities:
    Purchase of business, net of cash acquired

     

    (664

    )

     

    -

     

    Sale of business, net of cash and cash equivalents sold

     

    21,410

     

     

    -

     

    Investment in software development

     

    (13,666

    )

     

    (17,981

    )

    Purchases of property and equipment

     

    (1,277

    )

     

    (332

    )

    Net cash provided by (used in) investing activities

     

    5,803

     

     

    (18,313

    )

     
    Financing activities:
    Payments of long-term debt principal

     

    (6,625

    )

     

    (2,625

    )

    Proceeds from revolving line of credit

     

    23,765

     

     

    9,716

     

    Payments of revolving line of credit

     

    (39,072

    )

     

    (5,000

    )

    Debt issuance costs

     

    (529

    )

     

    -

     

    Treasury stock purchases

     

    (402

    )

     

    (2,575

    )

    Net cash used in financing activities

     

    (22,863

    )

     

    (484

    )

     
    Increase (decrease) in cash and cash equivalents

     

    4,779

     

     

    (5,478

    )

     
    Change in cash and cash equivalents included in assets sold

     

    (41

    )

     

    -

     

    Cash and cash equivalents, beginning of period

     

    3,848

     

     

    6,951

     

    Cash and cash equivalents, end of period

    $

    8,586

     

    $

    1,473

     

    TruBridge, Inc.
    Consolidated Bookings
    (In '000s)
    (Unaudited) (Non-GAAP)
     
    Three Months Ended September 30, Nine Months Ended September 30,

     

    2024

     

    2023 (3)

     

    2024

     

    2023 (3)

    Financial Health(1)

    $

    12,496

    $

    9,080

    $

    40,346

    $

    34,828

    Patient Care(2)

     

    8,454

     

    5,897

     

    27,464

     

    20,966

     
    Total

    $

    20,950

    $

    14,977

    $

    67,810

    $

    55,794

     

    (1)

    Generally calculated as the total contract price (for non-recurring, project-related amounts) and annualized contract value (for recurring amounts).

    (2)

    Generally calculated as the total contract price (for system sales) and annualized contract value (for support) for perpetual license system sales and total contract price for SaaS sales.

    (3)

    Adjustment was made to the 2023 bookings, due to 3rd Party Software, and Forms and Supplies being doubled accounted for in the total Patient Care bookings.
    TruBridge, Inc.
    Bookings Composition
    (In '000s, except per share data)
    (Unaudited) (Non-GAAP)
     
    Three Months Ended September 30, Nine Months Ended September 30,

    2024

    2023 (4)

    2024

    2023 (4)

    Financial Health
    Net new(1)

    $

    6,112

    $

    4,387

    $

    21,559

    $

    13,810

    Cross-sell(1)

     

    6,384

     

    4,693

     

    18,787

     

    21,018

    Patient Care
    Non-subscription sales(2)

     

    5,006

     

    3,126

     

    12,540

     

    12,124

    Subscription revenue(3)

     

    3,448

     

    2,771

     

    14,924

     

    8,842

     
    Total

    $

    20,950

    $

    14,977

    $

    67,810

    $

    55,794

     

    (1)

    "Net new" represents bookings from outside the Company's core Patient Care client base, and "Cross-sell" represents bookings from existing Patient Care customers. In each case, such bookings are generally comprised of recurring revenues to be recognized ratably over a one-year period and an average timeframe for commencement of bookings-to-revenue conversion of four to six months following contract execution.

    (2)

    Represents nonrecurring revenues that generally exhibit a timeframe for bookings-to-revenue conversion of five to six months following contract execution.

    (3)

    Represents recurring revenues to be recognized on a monthly basis over a weighted-average contract period of five years, with a start date in the next 12 months and an average timeframe for commencement of bookings-to-revenue conversion of five to six months following contract execution.

    (4)

    Adjustment was made to the 2023 bookings, due to 3rd Party Software, and Forms and Supplies being doubled accounted for in the total Patient Care bookings.

    TruBridge, Inc.
    Adjusted EBITDA - by Segment
    (In '000s)
    (Unaudited) (Non-GAAP)
     
    Three Months Ended September 30, Nine Months Ended September 30,
    In '000s

    2024

    2023

    2024

    2023

    Financial Health

    $

    9,562

    $

    4,623

    $

    23,767

    $

    18,205

    Patient Care

     

    4,260

     

    5,099

     

    12,083

     

    17,388

     
    Total

    $

    13,822

    $

    9,722

    $

    35,850

    $

    35,593

    TruBridge, Inc.
    Reconciliation of Non-GAAP Financial Measures
    (In '000s)
    (Unaudited)
     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    Adjusted EBITDA:

    2024

     

    2023

     

    2024

     

    2023

    Net loss, as reported

    $

    (9,809

    )

    $

    (3,562

    )

    $

    (17,374

    )

    $

    (3,315

    )

    Net Income Margin

     

    (11.7

    %)

     

    (4.3

    %)

     

    (6.9

    %)

     

    (1.3

    %)

     
    Depreciation expense

     

    279

     

     

    297

     

     

    1,079

     

     

    1,392

     

    Amortization of software development costs

     

    3,057

     

     

    2,194

     

     

    11,779

     

     

    5,506

     

    Amortization of acquisition-related intangibles

     

    3,126

     

     

    4,014

     

     

    9,379

     

     

    12,043

     

    Stock-based compensation

     

    1,398

     

     

    1,038

     

     

    3,698

     

     

    2,162

     

    Severance and other non-recurring charges

     

    4,018

     

     

    7,392

     

     

    12,449

     

     

    15,313

     

    Interest expense

     

    3,777

     

     

    2,847

     

     

    11,826

     

     

    7,719

     

    Change in fair value of contingent consideration

     

    (1,044

    )

     

    -

     

     

    (1,044

    )

     

    -

     

    Loss on disposal of property and equipment

     

    1,648

     

     

    -

     

     

    1,648

     

     

    117

     

    Gain on sale of AHT

     

    28

     

     

    -

     

     

    (1,221

    )

     

    -

     

    Provision (benefit) for income taxes

     

    7,344

     

     

    (4,498

    )

     

    3,631

     

     

    (5,344

    )

     
    Total Adjusted EBITDA

    $

    13,822

     

    $

    9,722

     

    $

    35,850

     

    $

    35,593

     

    Adjusted EBITDA Margin

     

    16.5

    %

     

    11.8

    %

     

    14.2

    %

     

    14.0

    %

    TruBridge, Inc.
    Reconciliation of Non-GAAP Financial Measures
    (In '000s, except per share data)
    (Unaudited)
     
    Three Months Ended September 30, Nine Months Ended September 30,
    Non-GAAP Net Income (loss) and Non-GAAP EPS:

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

    Net loss, as reported

    $

    (9,809

    )

    $

    (3,562

    )

    $

    (17,374

    )

    $

    (3,315

    )

     
    Pre-tax adjustments for Non-GAAP EPS:
    Amortization of acquisition-related intangible assets

     

    3,126

     

     

    4,014

     

     

    9,379

     

     

    12,043

     

    Stock-based compensation

     

    1,398

     

     

    1,038

     

     

    3,698

     

     

    2,162

     

    Severance and other nonrecurring charges

     

    4,018

     

     

    7,392

     

     

    12,449

     

     

    15,313

     

    Non-cash interest expense

     

    107

     

     

    90

     

     

    314

     

     

    270

     

    After-tax adjustments for Non-GAAP EPS:
    Tax-effect of pre-tax adjustments, at 21%

     

    (1,816

    )

     

    (2,632

    )

     

    (5,426

    )

     

    (6,255

    )

    Tax shortfall (windfall) from stock-based compensation

     

    13

     

     

    8

     

     

    126

     

     

    65

     

     
    Non-GAAP net income (loss)

    $

    (2,963

    )

    $

    6,348

     

    $

    3,166

     

    $

    20,283

     

     
    Weighted average shares outstanding, diluted

     

    14,323

     

     

    14,205

     

     

    14,290

     

     

    14,181

     

     
    Non-GAAP EPS

    $

    (0.21

    )

    $

    0.45

     

    $

    0.22

     

    $

    1.43

     

    TruBridge, Inc.
    Patient Care Revenue Composition
    (In '000s)
    (Unaudited)
     

    Three Months Ended September 30,

    Nine Months Ended September 30,

    2024

    2023

    2024

    2023

    Recurring revenues - Patient Care
    Acute care

    $

    26,584

    $

    29,068

    $

    80,726

    $

    88,420

    Post-acute care

     

    -

     

    3,594

     

    597

     

    11,230

    Total recurring revenues - Patient Care

     

    26,584

     

    32,662

     

    81,323

     

    99,650

     
    Non-recurring revenues - Patient Care
    Acute care

     

    2,975

     

    3,118

     

    8,996

     

    9,869

    Post-acute care

     

    -

     

    350

     

    70

     

    1,075

    Total non-recurring revenues - Patient Care

     

    2,975

     

    3,468

     

    9,066

     

    10,944

     
    Total Patient Care revenues

    $

    29,559

    $

    36,130

    $

    90,389

    $

    110,594

    Explanation of Non-GAAP Financial Measures

    We report our financial results in accordance with accounting principles generally accepted in the United States of America, or "GAAP." However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

    As such, to supplement the GAAP information provided, we present in this press release and during the live webcast discussing our financial results the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net income, and Non-GAAP earnings per share ("EPS").

    We calculate each of these non-GAAP financial measures as follows:

    • Adjusted EBITDA – Adjusted EBITDA consists of GAAP net income as reported and adjusts for (i) depreciation expense; (ii) amortization of software development costs; (iii) amortization of acquisition-related intangibles; (iv) stock-based compensation; (v) severance and other nonrecurring charges; (vi) interest expense; (vii) change in fair value of contingent consideration; (viii) loss on asset held for sale; (ix) gain on sale of AHT; and (x) the provision (benefit) for income taxes.
    • Adjusted EBITDA Margin – Adjusted EBITDA Margin is calculated as Adjusted EBITDA, as defined above, divided by total revenue.
    • Non-GAAP net income – Non-GAAP net income consists of GAAP net income as reported and adjusts for (i) amortization of acquisition-related intangible assets; (ii) stock-based compensation; (iii) severance and other non-recurring charges; (iv) non-cash interest expense; (v) gain on sale of AHT; and (vi) the total tax effect of items (i) through (v).
    • Non-GAAP EPS – Non-GAAP EPS consists of Non-GAAP net income, as defined above, divided by weighted average shares outstanding (diluted) in the applicable period.

    Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:

    • Amortization of acquisition-related intangibles – Acquisition-related amortization expense is a non-cash expense arising primarily from the acquisition of intangible assets in connection with acquisitions or investments. We exclude acquisition-related amortization expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired intangible assets. Investors should note that the use of these intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation, and the related amortization expense will recur in future periods.
    • Stock-based compensation – Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards. We exclude stock-based compensation expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of the timing and valuation of grants of new stock-based awards, including grants in connection with acquisitions. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods, and such expense will recur in future periods.
    • Severance and other nonrecurring charges – Non-recurring charges relate to certain severance and other charges incurred in connection with activities that are considered non-recurring. We exclude non-recurring expenses (primarily related to costs associated with our recent business transformation initiative and transaction-related costs) from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods.
    • Non-cash Interest expense – Non-cash interest expense includes amortization of deferred debt issuance costs. We exclude non-cash interest expense from non-GAAP financial measures because we believe these non-cash amounts relate to specific transactions and, as such, may not directly correlate to the underlying performance of our business operations.
    • Interest expense: Interest expense represents (i) interest incurred on our term loan and revolving credit facility and (ii) non-cash interest expense. We exclude interest expense from non-GAAP financial measures because we believe these amounts relate to specific transactions and, as such, may not directly correlate to the underlying performance of our business operations.
    • Change in fair value of contingent consideration: The purchase agreement for our acquisition of Viewgol in 2023 contained contingent consideration, or "earnout," provisions whereby the previous shareholders of Viewgol would receive additional consideration depending on the achievement of certain performance metrics. After the initial measurement period, U.S. GAAP requires that any adjustments to the estimated fair value of this contingent liability, including upon final determination of amounts due, should be recorded in the relevant period's earnings. We exclude gains on contingent consideration from non-GAAP financial measures because we believe (i) the amount of such gains in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such gains can vary significantly between periods.
    • Loss on assets held for sale: Loss on assets held for sale represents the excess of book value of assets sold over the proceeds received in connection with the sale of real estate assets during the period. We exclude loss on sale of real estate assets held for sale from non-GAAP financial measures because we believe (i) the amount of such gains gain or loss in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such gains gain or loss can vary significantly between periods.
    • Gain on sale of AHT: Gain on sale of AHT represents the excess of proceeds received over the net assets sold from our sale of AHT, our previously wholly-owned post-acute business, in January 2024. We exclude gain on sale of AHT from non-GAAP financial measures because we believe the amount relates to specific transaction and, as such, may not directly correlate to the underlying performance of our business operations
    • Tax shortfall (windfall) from stock-based compensation – ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, became effective for the Company during the third quarter of 2017 and changes the treatment of tax shortfall and excess tax benefits arising from stock based compensation arrangements. Prior to ASU 2016-09, these amounts were recorded as an increase (for excess benefits) or decrease (for shortfalls) to additional paid-in capital. With the adoption of ASU 2016-09, these amounts are now captured in the period's income tax expense. We exclude this component of income tax expense from non-GAAP financial measures because we believe (i) the amount of such expenses or benefits in any specific period may not directly correlate to the underlying performance of our business operations; and (ii) such expenses or benefits can vary significantly between periods as a result of the valuation of grants of new stock-based awards, the timing of vesting of awards, and periodic movements in the fair value of our common stock.

    Management considers these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition, management may use Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure the achievement of performance objectives under the Company's stock and cash incentive programs. Note, however, that these non-GAAP financial measures are performance measures only, and they do not provide any measure of cash flow or liquidity. Non-GAAP financial measures are not alternatives for measures of financial performance prepared in accordance with GAAP and may be different from similarly titled non-GAAP measures presented by other companies, limiting their usefulness as comparative measures. Non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Additionally, there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculations of the non-GAAP financial measures presented in this press release. Investors and potential investors are encouraged to review the "Unaudited Reconciliation of Non-GAAP Financial Measures" above.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241107152480/en/

    Get the next $TBRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TBRG

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $TBRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital Mkts initiated coverage on TruBridge with a new price target

      RBC Capital Mkts initiated coverage of TruBridge with a rating of Outperform and set a new price target of $13.00

      3/28/24 7:48:40 AM ET
      $TBRG
      EDP Services
      Technology

    $TBRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner L6 Holdings Inc. bought $1,764,561 worth of shares (65,524 units at $26.93) and bought $870,013 worth of shares (31,083 units at $27.99) (SEC Form 4)

      4 - TruBridge, Inc. (0001169445) (Issuer)

      3/21/25 4:52:58 PM ET
      $TBRG
      EDP Services
      Technology
    • President and CEO Fowler Christopher L bought $179 worth of shares (16 units at $11.16) (SEC Form 4)

      4 - TruBridge, Inc. (0001169445) (Issuer)

      2/27/25 4:36:54 PM ET
      $TBRG
      EDP Services
      Technology
    • Large owner L6 Holdings Inc. bought $859,062 worth of shares (30,377 units at $28.28) and bought $2,450,347 worth of shares (87,232 units at $28.09) (SEC Form 4)

      4 - TruBridge, Inc. (0001169445) (Issuer)

      2/26/25 5:21:35 PM ET
      $TBRG
      EDP Services
      Technology

    $TBRG
    Leadership Updates

    Live Leadership Updates

    See more
    • TruBridge Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments

      Jerry Canada, Former Group President of Harris Computer, a subsidiary of Constellation Software (TSX:CSU), and Andris (Dris) Upitis, Head of Ocho Investments LLC, join the TruBridge Board of Directors TruBridge, Inc. ("TruBridge" or the "Company") (NASDAQ:TBRG), a healthcare solutions company, today announced that it has entered into cooperation agreements with Pinetree Capital Ltd. and L6 Holdings Inc. (together, "Pinetree") and with Ocho Investments LLC ("Ocho"). Pinetree and Ocho are the Company's two largest investors. Pursuant to the agreements, TruBridge has appointed Jerry Canada and Dris Upitis to its Board of Directors (the "Board"), effective February 11, 2025. Canada and Upit

      2/11/25 8:00:00 AM ET
      $TBRG
      EDP Services
      Technology
    • Guidewire Appoints Mark Anquillare as Board Member

      Veteran P&C Insurance Analytics Leader Brings Deep Expertise to Guidewire's Board of Directors Guidewire (NYSE:GWRE) today announced that it appointed Mark Anquillare to its Board of Directors effective September 23, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240925715389/en/Mark Anquillare joins Guidewire Software's Board of Directors. (Photo: Business Wire) "We are thrilled to welcome Mark Anquillare to the Guidewire Board of Directors. With Guidewire Cloud Platform now established as the trusted platform used by P&C insurers globally, we are uniquely positioned to further embed data, analytics, and AI throughout ins

      9/25/24 4:15:00 PM ET
      $GWRE
      $TBRG
      $VRSK
      Computer Software: Prepackaged Software
      Technology
      EDP Services

    $TBRG
    Financials

    Live finance-specific insights

    See more
    • TruBridge Announces First Quarter 2025 Results

      TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights* All comparisons are to the quarter ended March 31, 2024, unless otherwise noted Total bookings of $22.0 million compared to $23.6 million Total revenue of $87.2 million compared to $84.1 million Recurring revenue represented 94% of total revenue Financial Health revenue of $56.1 million compared to $53.4 million Financial Health revenue represented 64% of TruBridge's total revenue GAAP net income of $0.5 million compared to a net loss of $1.9 million Non-GAAP net income of $5.2 million compared to $3.4

      5/7/25 4:05:00 PM ET
      $TBRG
      EDP Services
      Technology
    • TruBridge Announces First Quarter 2025 Conference Call to Be Held Wednesday, May 7, 2025

      TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that it will release its financial results for the first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. The Company will host a conference call at 3:30 p.m. Central Time, 4:30 p.m. Eastern Time the same day. To access this interactive teleconference, dial (888) 396-8049 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's website, www.trubridge.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. About TruB

      5/1/25 11:00:00 AM ET
      $TBRG
      EDP Services
      Technology
    • TruBridge Announces Fourth Quarter and Full Year 2024 Results and Provides Initial 2025 Outlook

      Revenue of $339.2 million for 2024 and $87.4 million in the fourth quarter Net loss of $23.1 million for 2024 and $5.7 million in the fourth quarter Adjusted EBITDA of $53.1 million for 2024 and $17.2 million in the fourth quarter TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the fourth quarter and year ended December 31, 2024. 2024 Operational Highlights Rebranded as TruBridge to pursue a more focused marketing strategy under one brand Achieved total annual bookings of $82.1 million Achieved solid organic growth in Financial Health (the revenue cycle management (RCM) business) Improved the quality of the Company's finan

      3/10/25 4:05:00 PM ET
      $TBRG
      EDP Services
      Technology

    $TBRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $TBRG
    SEC Filings

    See more
    • Controller Macintyre Vita covered exercise/tax liability with 188 shares, decreasing direct ownership by 7% to 2,425 units (SEC Form 4)

      4 - TruBridge, Inc. (0001169445) (Issuer)

      3/31/25 2:25:25 PM ET
      $TBRG
      EDP Services
      Technology
    • Amendment: Financial Health GM Wilson Merideth was granted 7,440 shares (SEC Form 4)

      4/A - TruBridge, Inc. (0001169445) (Issuer)

      3/26/25 2:53:13 PM ET
      $TBRG
      EDP Services
      Technology
    • Large owner L6 Holdings Inc. bought $1,764,561 worth of shares (65,524 units at $26.93) and bought $870,013 worth of shares (31,083 units at $27.99) (SEC Form 4)

      4 - TruBridge, Inc. (0001169445) (Issuer)

      3/21/25 4:52:58 PM ET
      $TBRG
      EDP Services
      Technology
    • SEC Form S-8 filed by TruBridge Inc.

      S-8 - TruBridge, Inc. (0001169445) (Filer)

      5/13/25 4:16:00 PM ET
      $TBRG
      EDP Services
      Technology
    • SEC Form 10-Q filed by TruBridge Inc.

      10-Q - TruBridge, Inc. (0001169445) (Filer)

      5/9/25 2:06:45 PM ET
      $TBRG
      EDP Services
      Technology
    • TruBridge Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - TruBridge, Inc. (0001169445) (Filer)

      5/8/25 4:15:38 PM ET
      $TBRG
      EDP Services
      Technology

    $TBRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • TruBridge Announces First Quarter 2025 Results

      TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights* All comparisons are to the quarter ended March 31, 2024, unless otherwise noted Total bookings of $22.0 million compared to $23.6 million Total revenue of $87.2 million compared to $84.1 million Recurring revenue represented 94% of total revenue Financial Health revenue of $56.1 million compared to $53.4 million Financial Health revenue represented 64% of TruBridge's total revenue GAAP net income of $0.5 million compared to a net loss of $1.9 million Non-GAAP net income of $5.2 million compared to $3.4

      5/7/25 4:05:00 PM ET
      $TBRG
      EDP Services
      Technology
    • TruBridge Announces First Quarter 2025 Conference Call to Be Held Wednesday, May 7, 2025

      TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that it will release its financial results for the first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. The Company will host a conference call at 3:30 p.m. Central Time, 4:30 p.m. Eastern Time the same day. To access this interactive teleconference, dial (888) 396-8049 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's website, www.trubridge.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. About TruB

      5/1/25 11:00:00 AM ET
      $TBRG
      EDP Services
      Technology
    • TruBridge Announces Fourth Quarter and Full Year 2024 Results and Provides Initial 2025 Outlook

      Revenue of $339.2 million for 2024 and $87.4 million in the fourth quarter Net loss of $23.1 million for 2024 and $5.7 million in the fourth quarter Adjusted EBITDA of $53.1 million for 2024 and $17.2 million in the fourth quarter TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced financial results for the fourth quarter and year ended December 31, 2024. 2024 Operational Highlights Rebranded as TruBridge to pursue a more focused marketing strategy under one brand Achieved total annual bookings of $82.1 million Achieved solid organic growth in Financial Health (the revenue cycle management (RCM) business) Improved the quality of the Company's finan

      3/10/25 4:05:00 PM ET
      $TBRG
      EDP Services
      Technology

    $TBRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by TruBridge Inc.

      SC 13G/A - TruBridge, Inc. (0001169445) (Subject)

      11/12/24 5:57:18 PM ET
      $TBRG
      EDP Services
      Technology
    • Amendment: SEC Form SC 13D/A filed by TruBridge Inc.

      SC 13D/A - TruBridge, Inc. (0001169445) (Subject)

      11/5/24 5:00:31 PM ET
      $TBRG
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by TruBridge Inc.

      SC 13G/A - TruBridge, Inc. (0001169445) (Subject)

      11/4/24 1:56:54 PM ET
      $TBRG
      EDP Services
      Technology